| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-07-09 16:08:55 UTC |
|---|
| Update Date | 2019-07-23 07:15:26 UTC |
|---|
| HMDB ID | HMDB0060947 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | desmethylclomipramine |
|---|
| Description | desmethylclomipramine belongs to the class of organic compounds known as dibenzazepines. Dibenzazepines are compounds with two benzene rings connected by an azepine ring. Azepine is an unsaturated seven-member heterocycle with one nitrogen atom replacing a carbon atom. Based on a literature review a significant number of articles have been published on desmethylclomipramine. |
|---|
| Structure | CNCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2 InChI=1S/C18H21ClN2/c1-20-11-4-12-21-17-6-3-2-5-14(17)7-8-15-9-10-16(19)13-18(15)21/h2-3,5-6,9-10,13,20H,4,7-8,11-12H2,1H3 |
|---|
| Synonyms | | Value | Source |
|---|
| N-Demethylclomipramine | HMDB | | Desmethylclomipramine hydrochloride | HMDB | | Demethylchlorimipramine | HMDB | | Desmethylchlorimipramine | HMDB |
|
|---|
| Chemical Formula | C18H21ClN2 |
|---|
| Average Molecular Weight | 300.826 |
|---|
| Monoisotopic Molecular Weight | 300.139326389 |
|---|
| IUPAC Name | (3-{14-chloro-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-2-yl}propyl)(methyl)amine |
|---|
| Traditional Name | (3-{14-chloro-2-azatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-2-yl}propyl)(methyl)amine |
|---|
| CAS Registry Number | 303-48-0 |
|---|
| SMILES | CNCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2 |
|---|
| InChI Identifier | InChI=1S/C18H21ClN2/c1-20-11-4-12-21-17-6-3-2-5-14(17)7-8-15-9-10-16(19)13-18(15)21/h2-3,5-6,9-10,13,20H,4,7-8,11-12H2,1H3 |
|---|
| InChI Key | VPIXQGUBUKFLRF-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dibenzazepines. Dibenzazepines are compounds with two benzene rings connected by an azepine ring. Azepine is an unsaturated seven-member heterocycle with one nitrogen atom replacing a carbon atom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzazepines |
|---|
| Sub Class | Dibenzazepines |
|---|
| Direct Parent | Dibenzazepines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Dibenzazepine
- Alkyldiarylamine
- Tertiary aliphatic/aromatic amine
- Azepine
- Aryl chloride
- Aryl halide
- Benzenoid
- Tertiary amine
- Secondary amine
- Secondary aliphatic amine
- Azacycle
- Hydrocarbon derivative
- Organonitrogen compound
- Organochloride
- Organohalogen compound
- Organopnictogen compound
- Organic nitrogen compound
- Amine
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.72 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 13.3375 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.75 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1612.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 331.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 179.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 196.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 134.4 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 459.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 425.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 221.4 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1265.6 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 509.2 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1335.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 339.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 354.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 300.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 128.2 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 7.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| desmethylclomipramine,1TMS,isomer #1 | CN(CCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21)[Si](C)(C)C | 2587.9 | Semi standard non polar | 33892256 | | desmethylclomipramine,1TMS,isomer #1 | CN(CCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21)[Si](C)(C)C | 2797.9 | Standard non polar | 33892256 | | desmethylclomipramine,1TMS,isomer #1 | CN(CCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21)[Si](C)(C)C | 3242.9 | Standard polar | 33892256 | | desmethylclomipramine,1TBDMS,isomer #1 | CN(CCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21)[Si](C)(C)C(C)(C)C | 2805.8 | Semi standard non polar | 33892256 | | desmethylclomipramine,1TBDMS,isomer #1 | CN(CCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21)[Si](C)(C)C(C)(C)C | 3095.9 | Standard non polar | 33892256 | | desmethylclomipramine,1TBDMS,isomer #1 | CN(CCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21)[Si](C)(C)C(C)(C)C | 3348.1 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - desmethylclomipramine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-6090000000-9eed19a2ef45fc520c90 | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - desmethylclomipramine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - desmethylclomipramine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - desmethylclomipramine 10V, Positive-QTOF | splash10-0uk9-1069000000-86dede74ad37de04b372 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - desmethylclomipramine 20V, Positive-QTOF | splash10-00dl-6093000000-595de34abeb5c6686672 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - desmethylclomipramine 40V, Positive-QTOF | splash10-0006-9240000000-ac7e79f4ac427320c754 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - desmethylclomipramine 10V, Negative-QTOF | splash10-0002-0090000000-f1e765f5a26c70ab77d7 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - desmethylclomipramine 20V, Negative-QTOF | splash10-002b-1090000000-1ddc75254b4387dae329 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - desmethylclomipramine 40V, Negative-QTOF | splash10-0fbc-2390000000-bb1e61bf6aeb82c055f0 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - desmethylclomipramine 10V, Positive-QTOF | splash10-0udi-2009000000-c20e525f00993d151f84 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - desmethylclomipramine 20V, Positive-QTOF | splash10-0fk9-4095000000-6701457843879edd44f4 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - desmethylclomipramine 40V, Positive-QTOF | splash10-0096-9040000000-fdf055a6b5c0574ca702 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - desmethylclomipramine 10V, Negative-QTOF | splash10-0002-0090000000-228c0f7f447a837fde13 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - desmethylclomipramine 20V, Negative-QTOF | splash10-002b-0090000000-0c7b194f8eae2f796bbd | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - desmethylclomipramine 40V, Negative-QTOF | splash10-004i-2090000000-e19659de1a99730937fb | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|